drugset / Trial / NCT00912262

A Study to Investigate the Tolerability and Effects on Epidermal Nerve Fiber Density of Multiple Low-Concentrations of NGX-1998 in Healthy Volunteers

NCT00912262

Phase 1 Completed 36 enrolled NeurogesX
RandomizedSingle-groupSingle-blindTreatment

Summary

The purpose of this single-blinded study in healthy volunteers is to select a Low-Concentration Capsaicin Topical Liquid (LC-CTL) to serve as a control formulation in the further clinical development of Capsaicin Topical Liquid, NGX-1998 (10% w/w). The goal is to identify a low concentration formulation that will not reduce ENFD in healthy normal volunteers when compared to NGX-1998 (10% w/w) but would still produce some local capsaicin-related application site responses (e.g. erythema, heat sensation or pain) when applied.

Timeline

Start
2008-06
Primary completion
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Capsaicin Small molecule 0.001 % Topical
Comparator Capsaicin Small molecule 0.003 % Topical
Comparator Capsaicin Small molecule 0.1 % Topical
Comparator Capsaicin Small molecule 0.3 % Topical
Comparator Capsaicin Small molecule 1 % Topical
Comparator Capsaicin Small molecule 10 % Topical

Indications

No indication recorded.